Reuters logo
BRIEF-Sonoma Pharmaceuticals announces FDA approval of expanded indication for Alevicyn
November 16, 2017 / 1:17 PM / a month ago

BRIEF-Sonoma Pharmaceuticals announces FDA approval of expanded indication for Alevicyn

Nov 16 (Reuters) - Sonoma Pharmaceuticals Inc:

* Announces FDA approval of expanded indication for Alevicyn to add antimicrobial language

* Approved Alevicyn dermal spray, to include antimicrobial language and antimicrobial data against clinically relevant microorganisms​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below